World Sleep 2025 - Scientific Program Bundle
-
Register
- Non-member - $900
- Regular Member - $450
- Student Member - $450
- Technician Member - $450
After purchasing the bundle, navigate to the Content tab and activate sessions of interest to add them to your dashboard.
This bundle gives you access to the following sessions:
Keynotes
- K-01: Thomas Penzel: Innovations in sleep technology: Advancing diagnosis and treatment of sleep disorders
- K-02: Russell Foster: Light, circadian rhythms and sleep: Fundamental mechanisms to new therapeutics
- K-03: Tiina Paunio: Sleep and development: Exploring the impact of sleep on mental health in children
- K-04: Hiroki R. Ueda: Towards human systems biology of sleep/wake cycles: The role of calcium and phosphorylation in sleep
- K-05: Lauren Hale: Sleep health as a human right
- K-06: Bei Bei: Behavioral sleep interventions in women across the lifespan
- K-07: Mary Ip: Cardiometabolic consequences of obstructive sleep apnea: Are we making progress?
- K-08: Célyne Bastien: Sleep misperception: A waking perspective
- K-09: Takafumi Kato: Advances in dental sleep medicine: Understanding the pathophysiology of sleep bruxism and co-existing sleep disorders
- K-10: Ronald Postuma: REM sleep behavior disorder: Gateway to early diagnosis and therapy in synucleinopathies
- K-11: Björn Rasch: Sleep and memory: Current state of research and future needs
- K-12: Joshua J. Gooley: The hard facts supporting later learning start times
Symposia
- S-01: Pharmacotherapy of obstructive sleep apnea in 2025
- S-02: The Global Adolescent Sleep Project (GASP): A Summary of the Findings, Research Gaps and Future Directions
- S-03: Challenges of using cognitive behavioral treatment for insomnia in specific patient groups and settings
- S-04: WSS Task Force recommendations for use of consumer health trackers for sleep tracking
- S-05: OSA, neurodegeneration and neurocognitive decline: New insights and future directions
- S-06: Sleep health and aging: A decade research and its global implications
- S-07: Hypersomnolence in focus: Orexin as the key to treating comorbidities and secondary diseases?
- S-08: Decoding neurological sleep disorders: Genetic and omics approaches to advance clinical practice
- S-09: The medical and dental aspects of Asian and Caucasian populations in cardiosleep outcomes with oral appliance therapy on sleep-disordered breathing, blood pressure control, and maladaptive myocardial remodelling
- S-10: Mechanisms underlying REM sleep memory modification
- S-11: Prefrontal cortical orchestration of sleep: The missing link between sleep disruption and psychiatric disease?
- S-12: Narcolepsy: Examining the science, impact, and current unmet needs
- S-13: World Health Organization report on road safety: Pathway to global professional driver work hours regulations
- S-14: 45 years on from CPAP: Therapeutic options for pediatric OSA
- S-15: Sleep loss increases intrusive memories: But, how?
- S-16: Sleep and health problems among shift workers across the world: Novel findings, challenges, and future perspectives
- S-17: Discussion group: Leading the charge: Sleep medicine’s role in a healthier planet
- S-18: iRBD biomarkers through the lens of young scientists: What do we have and what do we need?
- S-19: Associations of accelerometry-derived sleep variables with age-related disease outcomes and variations across sociodemographic groups and wearing time: Findings from the CHARGE Accelerometry Working Group
- S-20: Exploring the intersections of sleep bruxism, orofacial pain, insomnia, and obstructive sleep apnea
- S-21: Current evidence on cardiometabolic diseases and sleep disorders; Asian Perspectives
- S-22: Patterns of plates and pillows: Exploring the bidirectional interplay between sleep and circadian rhythms, and eating behavior and metabolic outcomes
- S-23: Harnessing sensors and big data to decipher the link between sleep health and cardiovascular risk: Innovations and applications
- S-24: Novel approaches to address sleep problems in young children: Evidence from 5 randomized controlled trials
- S-25: Open data and open science in sleep medicine and sleep research
- S-26: Advancing biomarkers in isolated REM sleep behavior disorder: Pathways to clinical implementation
- S-27: Symptom subtypes of obstructive sleep apnea: Past, present, and future
- S-28: Global insights and emerging perspectives on sleep (ir)regularity
- S-29: ISSS symposium: Neurostimulation in the treatment obstructive sleep apnea: Current understanding, challenges and the future
- S-30: New insights and opportunities into sleep and pregnancy health with wearable big data and digital health interventions
- S-31: Sleep and digital media myth-busting: What should the recommended guidelines be for children, adolescents and young adults?
- S-32: Sleep, sleep disorders and neurodegenerative diseases: Novel insights on mechanisms and interventions
S-33: Global sleep health in turbulent times: Effects of political instability on funding, advocacy and health services(Session Not Available)- S-34: Discussion group: Artificial intelligence in sleep medicine: The good, the bad, the ugly
- S-35: Sleep-Immune interactions and the role of sleep in Long COVID
- S-36: Discussion group: Cannabis for the treatment of sleep disorders: What's the POT-ential?
- S-37: Social and neuropsychological outcomes in central disorders of hypersomnolence
- S-38: New circuits underlying REM sleep regulation and homoeostasis
- S-39: Sleep well, feel well: Enhancing mental health across the lifespan through sleep interventions
- S-40: Best of SLEEP MEDICINE – Journal Highlights 2025
- S-41: To wake up or continue sleep: Arousal dynamics and sleep stability in health and disease
- S-42: Revolutionizing personalized medicine in OSA: Exploring new treatment modalities
- S-43: Insomnia Sub-typing: Pathophysiology, phenotypes and differential treatment response
- S-44: Sleep and cardiometabolic health: Pathophysiology, and novel preventive and therapeutic strategies
- S-45: The role of autovideosomnography in research: How AI and big data are transforming pediatric sleep and development research
- S-46: How sleep shapes memory dynamics from the lens of reactivation: New insights and future directions
- S-47: Beyond the lab: Measuring sleep and circadian rhythms in naturalistic settings
- S-48: Discussion group: Optimizing opioid therapy for restless legs syndrome /Willis-Ekbom disease: Insights from basic science to clinical practice
- S-49: New insights into the waking, sleeping and dreaming brain
- S-50: Bridging sleep research and practice: Leveraging implementation science to improve sleep equity around the globe
S-51: The latest advances in understanding maternal sleep as a modifiable contributor to safer outcomes for mother and baby(Session Not Available)- S-52: Sleep Challenge 2025 Exhibition: Predicting all-cause mortality using physiological signals from the PSG
- S-53: Illuminating the minds: Impact of light exposure on circadian rhythms and health
- S-54: Advancing the definition and management of childhood obstructive sleep apnea (OSA)
- S-55: Advancing ambulatory sleep monitoring and diagnostics through innovative sensor technologies
- S-56: Obesity and the effects of GLP-1 agonists on OSA
- S-57: Narcolepsy meets immunology: Recent global discoveries in its pathophysiology
- S-58: Discussion group: Religious and spiritual determinants of sleep health
- S-59: Understanding the therapeutic opportunities of iron treatment in RLS
- S-60: Collaborative strategies for optimizing pediatric sleep health
- S-61: Sleep and the microbiome
S-62: Rethinking mask selection for CPAP and non-invasive ventilation: Facts and perspectives(Session Not Available)- S-63: Global efforts to combat drowsy driving: Opportunities and challenges to save more lives
- S-64: Discussion Group: Managing patients with obstructive sleep apnea and obesity with GLP-1 receptor agonists
- S-65: Night shift work and health risks: Internal desynchrony and underlying mechanisms
- S-66: Phenotypic spectrum of restless legs syndrome: Clinical insights and research perspectives
- S-67: Toward understanding dream interpretation: Mechanisms and functions of REM sleep
- S-68: Adolescent sleep and mental health: From challenges to solutions
- S-69: Discussion group: Global perspectives on sleep health advocacy: Insights and experiences across five continents
- S-70: Ecology of sleep strategies: Placing sleep function in a broader context
- S-71: Cracking the code: Deep signal analysis in sleep-disordered breathing
- S-72: Advances in proteomics, glycomics, and transcriptomics of sleep disorders
S-73: Discussion group: "Simple" snoring: Not simple, not hopeless(Session Not Available)- S-74: Harmonizing pediatric sleep: Navigating the complexities and diversities in managing sleep-related breathing disorders across borders
- S-75: Can OSA in adults be prevented by interventions in children?
- S-76: Practical telemonitoring implementation to improve outcomes in home mechanical ventilation globally, across diverse clinical settings and regions
- S-77: Restless legs syndrome and cardio-cerebro-vascular disease: Clinical associations and implications
- S-78: The role of glia in sleep regulation and sleep homeostasis: Implications for cognitive function and mental health
- S-79: Sleep as a window to health: Artificial intelligence-enabled digital sleep biomarkers for disease prediction
- S-80: Cognitive symptoms in narcolepsy and idiopathic hypersomnia: Neurobiology, functional impact, and clinical research
- S-81: Guiding light for metabolic health: Lessons from bench to field studies for therapeutic insights
- S-82: Tales from the edge: What can we learn about sleep from non-WEIRD (Western, Educated, Industrialized, Rich, and Democratic) sleep research?
- S-83: RBD 1985-2025: Novel perspectives
- S-84: Napping and its associations with health and cognition across the life span
- S-85: Consumer sleep technology: Usefulness and reliability for patients and practitioners
- S-86: AI approaches in pediatric sleep: Unraveling developmental sleep issues
- S-87: Innovative approaches to sleep Disorders and craniofacial health: Bridging research and clinical practice
- S-88: Gender disparities in obesity hypoventilation syndrome: From diagnosis and treatment to outcomes
- S-89: Novel developments in psychotherapy for insomnia
- S-90: Restless legs syndrome: Exploring genetic diversity, racial differences, and phenotypes
- S-91: The impact of sleep on frailty, sarcopenia, and falls: Investigating novel risk factors in aging populations
- S-92: The impact of war on sleep: Uncovering the mechanisms that link trauma exposure and sleep quality across different cohorts and age groups
- S-93: Unveiling and addressing sleep health disparities in indigenous peoples around the world
- S-94: The link between heart rate variability, autonomic alterations, and sleep disorders across lifespan and pathologies
- S-95: No strings attached: Harnessing novel contactless technology for sleep health and beyond
- S-96: Circadian rhythm sleep-wake disorders: Relevance to behavior and comorbidity
- S-97: Obstructive sleep, apnea: Studies by early-stage investigators
- S-98: Beyond the classical pentad: Narcolepsy from a multimodal perspective
- S-99: Promoting infant sleep in different cultures: Lessons from developing, adapting and evaluating innovative sleep interventions for infants in various cultures
- S-100: The rhythm of rest: Exploring the cognitive and psychological benefits and drawbacks associated with intraindividual variability in sleep
- S-101: ISSS symposium: The role of anatomic surgery in adult sleep apnea patients failing conventional treatments: Latest evidence and guidelines
- S-102: Digital advancements in oral appliance therapy for obstructive sleep apnea
- S-103: Cardiovascular implications of sleep disruption in women: Emerging evidence and clinical implications
- S-104: Shaping the future of sleep medicine: Evidence, innovations, and insights from Sleep Revolution
- S-105: Waking up the workforce: Exploring the impact of sleep on workplace performance, decision-making, and outcomes
- S-106: World clock: Turning back time on diagnostic delays in NT1
- S-107: Beyond scoring: Transforming sleep medicine with AI
- S-108: Sleep, sleep apnea, and heart rhythm: All you can learn
- S-109: Examining sleep contributions to pathways from stress to affective psychopathology in children and youth
- S-110: Chrononutrition to optimize health
- S-111: Translation of endo-phenotyping of adult obstructive sleep apnea to the clinic
- S-112: Targeting sleep disturbances in mental disorders: Does it make the difference?
- S-113: The mind throughout the sleep-wake cycle: The importance of cognitive phenomenology in sleep clinics
- S-114: New insights on the control of breathing during sleep and innovative genetic approaches for obstructive sleep apneas
- S-115: Sleep in athletes and the application to occupational settings
- S-116: The role of sleep and circadian factors for motivation and behavior
- S-117: Artificial intelligence approaches to physiologic signals in sleep medicine
- S-118: The molecular link between sleep and neurodevelopment
- S-119: Empowering women's sleep health through artificial intelligence
- S-120: Sleep and long COVID: From epidemiology to future prevention on behalf of Second International COVID-19 Sleep Study (ICOSS-II) group
- S-121: Novel sleep intervention trials for enhancing brain health across the lifespan
- S-122: Children's sleep in context: The role of social, economic, and educational policy and practice in early sleep development
- S-123: The waking nightmare: Unraveling the evidence behind the intertwined pathways between sleep and cancer
Oral Abstract Sessions
- O-01: Advancing surgical and neurostimulation therapies for obstructive sleep apnea
- O-02: Orexin-based therapies and pharmacological advances in narcolepsy
- O-03: Sleep health trajectories in childhood and adolescence
- O-04: Basic Science: Sleep deprivation and sleep disorder
- O-05: Optimizing therapeutic strategies and outcomes in obstructive sleep apnea management
- O-06: Innovations in the diagnosis and management of RLS
O-07: Dental and surgical sleep medicine interactions(Session Not Available)- O-08: Light and sleep health
- O-09: Targeting the orexin pathway: Emerging pharmacotherapies for narcolepsy type 1
- O-10: Novel approaches to treating insomnia
- O-11: Sleep in childhood and adolescence
- O-12: Basic research: Animal models of sleep and sleep disorder
- O-13: New sensing or signal analysis methods in sleep
- O-14: Sleep and circadian regulation of cognition and memory
- O-15: Psychiatric disorders affecting wake / sleep
- O-16: Sleep and aging brains: Patterns, risks, and predictive insights
- O-17: Biomarkers, phenotyping, and cognitive aspects in narcolepsy and hypersomnolence
- O-18: Tracking sleep: Tools, trends, and tailored interventions
- O-19: New Investigator Award
O-20: Sleep and sleep deprivation neurophysiology(Session Not Available)- O-21: Phenotyping and variability in obstructive sleep apnea: Implications for cardiovascular risk and personalized management
- O-22: The science of sleep health: Biomarkers, behavior, and big data
- O-23: Neurophysiological signatures and technological innovations in sleep apnea detection and impact assessment
O-24: Treatment and risk factor modifications in circadian rhythm disorders(Session Not Available)- O-25: Biomarkers and neuroimaging in prodromal RBD and synucleinopathies
- O-26: Infant and preschool sleep: Patterns and problems
- O-27: Rethinking daytime sleepiness: Multimodal approaches to identification and management
- O-28: Chronobiology and neurophysiology in early neurodegeneration
- O-29: Pediatric sleep-disordered breathing: Diagnostic innovation, biological mechanisms, and therapeutic strategies in complex and vulnerable populations
- O-30: Sleep and public health: Stress, climate, and community
- O-31: Management of insomnia with digital CBT-I
- O-32: Pathophysiological and diagnostic advances in RBD and NREM parasomnias
- O-33: Multisystem pathophysiology and biomarker discovery in sleep apnea
- O-34: Mechanisms and modulation of sleep-related cognitive dysfunction
- O-35: Novel sleep technology approaches with clinical applications
- O-36: Neurophysiology of sleep and cognitive aging
- O-37: Symptomatology, phenotypes, and pathophysiology of insomnia
Advanced Search This List
-
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below.
0:00:00
Next-Generation Hypoglossal Nerve Stimulation Therapy for the Treatment of Obstructive Sleep Apnea
Shaun Loh (Singapore)
0:12:35
Low Arousal Threshold as a Predictor of Hypoglossal Nerve Stimulation Therapy Adherence
Thomas Kaffenberger (United States)
0:38:00
The ‘USA’ System: A Novel Classification for Hypoglossal Nerve Stimulation Therapy Outcomes
Ryan Soose (United States)
0:52:35
Combined Hypoglossal Nerve and Ansa Cervicalis Stimulation Outperforms Single Interventions in Maintaining Airway Patency in Patients with Obstructive Sleep Apnea
Yike Li (United States)
1:07:50
International expert consensus statement: surgical failure in obstructive sleep apnea
Tiziano Perrone (Italy)
-
Contains 1 Component(s)
This Session has been made freely available as part of the Open Access Sessions bundle.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Oveporexton (TAK-861) Improves Wakefulness in People with NT1: Assessment of At-home Napping and In-clinic Microsleeps
Brian Tracey (United States)
0:13:50
Initial preclinical development of a novel dual orexin receptor agonist
Alessandro Silvani (Italy)
0:27:20
Optogenetic activation of the histaminergic system in the amygdala of narcoleptic mice reduces the occurrence of cataplexy
Christelle Peyron (France)
0:40:40
The Effect of Pitolisant on Sleep-Promoting Neurons
Thomas Scammell (United States)
0:50:00
iSPHYNCS: An Update on the Internationalization and New Approaches of the Swiss Primary HYpersomnolence and Narcolepsy Cohort Study
Markus Schmidt (Switzerland)
1:02:50
E2086, a Selective Orexin Receptor-2 Agonist, Study for Promoting Wakefulness in Patients With Narcolepsy Type-1
Jocelyn Cheng (United States)
-
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Relationships between childhood sleep health and mental health at 12-years: Findings from the Growing Up in New Zealand study
Diane (Dee) Muller (New Zealand)
0:14:40
Perinatal Subjective Sleep Disturbance and Circulating Cytokine Levels: Bidirectional Examinations
Michele Okun (United States)
0:30:20
Bi-directional associations between physical activity and sleep in school-age children: differences across times of day
Jia Xu Toby Seah (Singapore)
0:43:30
Bedtime at Midnight: Actigraphy-Measured Sleep Dimensions and Socioeconomic Predictors among Toddlers in Dhaka, Bangladesh
Ayesha Sania (United States)
0:58:35
Exploring the Sleep of Young Children in Aotearoa New Zealand: Associations with Ethnicity and Maternal Depression in and Beyond the Perinatal Period
Mikaela L. Carter (New Zealand)
1:13:30
Sleep Health Profile In Early Infancy Is Associated With Emerging Executive Function Development
Nicolò Pini (United States)
-
Contains 1 Component(s)
This Session has been made freely available as part of the Open Access Sessions bundle.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Maternal sleep disordered breathing impacts cortisol regulation in pregnancy
Margaret Bublitz (United States)
0:12:20
THC and CBD in insomnia associated to neuropathic pain: effect on sleep architecture and descending anti-nociceptive pathways
Martha Lopez-Canul (Canada)
0:26:00
Data-Driven Fatigue Management: Harmonising Predictive Models with Actual Pilot Data to Optimise Alertness and Performance
Paul Kirby (Australia)
0:42:10
Effects of Sleep Deprivation on Cognitive Performance and Neurovascular Coupling: A Functional Transcranial Doppler Study
Kannaphob Ladthavorlaphatt (Thailand)
0:54:25
Sleep architectural changes during recurrent cycles of sleep restriction: comparing stable and variable short sleep schedules
Tiffany B. Koa (Singapore)
1:11:40
Dopaminergic Mechanisms Underpinning Excessive Daytime Sleepiness and Hypoglossal Nerve Stimulation Outcomes in OSA: Evidence from Transcriptomics and Animal Models
Yan Wang (China)
-
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Benefits of Early Body Weight Reduction in Participants with Obesity and Moderate-to-severe Obstructive Sleep Apnea: A Post Hoc Analysis of SURMOUNT-OSA
Ying Ni Lin (China)
Recording not available: The Effect of Zolpidem on CPAP Acclimatization in Patients with OSA: A Crossover, Randomized, Double-blinded, Placebo-controlled Trial.
Piyakorn Pisalnoradej (Thailand)
0:14:23
The Effect of Telemedicine-Based CPAP Management on 24-Hour Ambulatory Blood Pressure in Patients with Obstructive Sleep Apnea: A Randomized, Controlled, Non-Inferiority Trial
Huiji Yi (China)
0:26:50
Real-World Evidence for Surgical and Nonsurgical Sleep Apnea Therapies: safety, Clinical Outcomes and Healthcare Utilization Patterns
Robson Capasso (United States)
0:48:45
Five-year, prospective, multicenter, real-world study to assess initial delivery, management and long-term effectiveness of a CAD/CAM, 3-D printed oral appliance in the treatment of obstructive sleep apnea: Interim Analysis Update
Robyn Woidtke (United States)
-
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Efficacy of transcutaneous spinal direct current stimulation and pneumatic compression in restless legs syndrome and augmentation
Nikita Gorbachev (Russian Federation)
0:09:10
Tonic motor activation therapy in patients with painful versus painless restless legs: An interim 180-day results from the THRIVE study
Elias Karroum (United States)
0:20:50
Clinical Characteristics, Polysomnography, and Iron Metabolism in Restless Legs Syndrome Patients with Obstructive Sleep Apnea: A Comparative and Cluster Analysis Study
Yanyan Hou (China)
0:34:25
Clinical influence of restless legs syndrome in migraine patients: a 12-year single-center longitudinal study
Keisuke Suzuki (Japan)
0:46:30
Impact of Dopamine Agonists and Clonazepam on LMM and PLMS in RLS Patients
Maria Paola Mogavero (Italy)
Raffaele Ferri (Italy)
Recording not available: Neurological approaches to restless legs syndrome: a systematic review of non-pharmacological interventions
Joao Victor Pereira Gonzalez (Brazil)
-
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Examining the impact of seasonal variations in photoperiod on sleep in young adults
Saranea Ganesan (United Kingdom)
0:10:00
Light Exposure Patterns and Human Health: Insights from Large-Scale Personal Light Tracking
Sean Cain (Australia)
0:24:20
Diurnal light exposure and circadian rest-activity rhythms with the risk of metabolic dysfunction-associated fatty liver disease
Hanshang Wu (China)
0:35:35
Light at Night Exacerbates Depression Risk via Circadian Disruption and Hippocampal Per1 Dysregulation: Translational Evidence from a Large-scale Prospective Cohort and Animal Study
Hongliang Feng (China)
0:50:40
Use of Apple Watch to Optimize Light Therapy and Reduce Circadian Misalignment for Night Shift Workers
Marleigh Treger (United States)
1:05:55
Blue light influences loss aversion
Alicia Lander (Australia)
-
Contains 1 Component(s)
This Session has been made freely available as part of the Open Access Sessions bundle.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the course by navigating to the timestamp indicated below
0:00:00
Vibrance-1: A Randomized Phase 2 Study Evaluating Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680) in Patients with Narcolepsy Type 1
Giuseppe Plazzi (Italy)
0:13:50
Improvement in the Severity of Narcolepsy Symptoms and Fatigue in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)
Yves Dauvilliers (France)
0:24:50
Improvement in Patient-reported Cognitive Functioning in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)
Giuseppe Plazzi (Italy)
0:35:00
The First Light: Efficacy and Safety of a Multi-Dose Study of Oveporexton (TAK-861), an Oral Orexin Receptor 2 Agonist for the Treatment of Narcolepsy Type 1
Emmanuel Mignot (United States)
0:47:50
The Radiant Light: Efficacy and Safety of Oveporexton (TAK-861), an Oral Orexin Receptor 2 Agonist for the Treatment of Narcolepsy Type 1
Yves Dauvilliers (France)
1:01:25
Effect of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) on the Severity of Symptoms in Individuals With Narcolepsy Type 1: Results From Two Phase 3 Studies
Lucie Barateau (France)
1:14:45
Effect of the Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) on Quality of Life in Individuals with NT1 over 12 weeks
Sheila Sivam (Australia)
-
Contains 1 Component(s)
This Session has been made freely available as part of the Open Access Sessions bundle.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Mindfulness-imbued insomnia therapy enhances antidepressant outcomes for pregnant women with insomnia and depression: A comparative effectiveness randomized controlled trial of CBTI and PUMAS
Heba Afaneh (United States)
0:14:25
Intensive Sleep Retraining and Total Sleep Deprivation for Treating Chronic Insomnia: A Randomised Controlled Trial
Charles Morin (Canada)
0:32:15
Effect of combined treatment with transcranial direct current stimulation and repetitive transcranial magnetic stimulation compared to monotherapy for the treatment of chronic insomnia: a randomised, double-blind, parallel-group, controlled trial
Qi Zhou (China)
0:46:55
Brain Network Study of Transcranial Plasma Therapy for Chronic Insomnia
Qinying Ma (China)
1:03:10
Novel Approach for Biologically-Guided Therapeutics in Insomnia
Carolina Gutierrez Herrera (Switzerland)
1:15:50
Effects of Music Presentation on Sleep Quality and Functional Connectivity in the Brain Estimated using EEG
Hiroto Irimajiri (Japan)
-
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Autism, Sleep, and Medicinal Cannabis: Evaluating 18-Month Efficacy and Safety Outcomes
Mohsin Maqbool (United States)
Recording not available: Integrated metagenomic and metabolomic analysis reveal distinctive gut microbiota-derived metabolites in pediatric obstructive sleep apnea
Xiaoman Zhang (China)
0:14:55
Achieving recommended sleep duration and abdominal fat deposition: a sex-specific relationship in 10-year-old children
Shirong Cai (Singapore)
0:24:50
Can sleep spindle characteristics distinguish children with narcolepsy from those with idiopathic hypersomnia and subjective sleepiness?
Rosemary Horne (Australia)
0:37:20
The temporal associations between sleep and circadian preference, and mental health among Norwegian adolescents
Ingvild West Saxvig (Norway)
0:50:05
Beyond the recommendations: A bioecological analysis of pre-bedtime screen use, moderate-to-vigorous physical activity and food intake in family contexts
Chao Gu (New Zealand)
1:01:30
Question and Answer
-
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below.
0:00:00
Next-Generation Hypoglossal Nerve Stimulation Therapy for the Treatment of Obstructive Sleep Apnea
Shaun Loh (Singapore)
0:12:35
Low Arousal Threshold as a Predictor of Hypoglossal Nerve Stimulation Therapy Adherence
Thomas Kaffenberger (United States)
0:38:00
The ‘USA’ System: A Novel Classification for Hypoglossal Nerve Stimulation Therapy Outcomes
Ryan Soose (United States)
0:52:35
Combined Hypoglossal Nerve and Ansa Cervicalis Stimulation Outperforms Single Interventions in Maintaining Airway Patency in Patients with Obstructive Sleep Apnea
Yike Li (United States)
1:07:50
International expert consensus statement: surgical failure in obstructive sleep apnea
Tiziano Perrone (Italy) -
Contains 1 Component(s)
This Session has been made freely available as part of the Open Access Sessions bundle.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Oveporexton (TAK-861) Improves Wakefulness in People with NT1: Assessment of At-home Napping and In-clinic Microsleeps
Brian Tracey (United States)
0:13:50
Initial preclinical development of a novel dual orexin receptor agonist
Alessandro Silvani (Italy)
0:27:20
Optogenetic activation of the histaminergic system in the amygdala of narcoleptic mice reduces the occurrence of cataplexy
Christelle Peyron (France)
0:40:40
The Effect of Pitolisant on Sleep-Promoting Neurons
Thomas Scammell (United States)
0:50:00
iSPHYNCS: An Update on the Internationalization and New Approaches of the Swiss Primary HYpersomnolence and Narcolepsy Cohort Study
Markus Schmidt (Switzerland)
1:02:50
E2086, a Selective Orexin Receptor-2 Agonist, Study for Promoting Wakefulness in Patients With Narcolepsy Type-1
Jocelyn Cheng (United States) -
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Relationships between childhood sleep health and mental health at 12-years: Findings from the Growing Up in New Zealand study
Diane (Dee) Muller (New Zealand)
0:14:40
Perinatal Subjective Sleep Disturbance and Circulating Cytokine Levels: Bidirectional Examinations
Michele Okun (United States)
0:30:20
Bi-directional associations between physical activity and sleep in school-age children: differences across times of day
Jia Xu Toby Seah (Singapore)
0:43:30
Bedtime at Midnight: Actigraphy-Measured Sleep Dimensions and Socioeconomic Predictors among Toddlers in Dhaka, Bangladesh
Ayesha Sania (United States)
0:58:35
Exploring the Sleep of Young Children in Aotearoa New Zealand: Associations with Ethnicity and Maternal Depression in and Beyond the Perinatal Period
Mikaela L. Carter (New Zealand)
1:13:30
Sleep Health Profile In Early Infancy Is Associated With Emerging Executive Function Development
Nicolò Pini (United States) -
Contains 1 Component(s)
This Session has been made freely available as part of the Open Access Sessions bundle.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Maternal sleep disordered breathing impacts cortisol regulation in pregnancy
Margaret Bublitz (United States)
0:12:20
THC and CBD in insomnia associated to neuropathic pain: effect on sleep architecture and descending anti-nociceptive pathways
Martha Lopez-Canul (Canada)
0:26:00
Data-Driven Fatigue Management: Harmonising Predictive Models with Actual Pilot Data to Optimise Alertness and Performance
Paul Kirby (Australia)
0:42:10
Effects of Sleep Deprivation on Cognitive Performance and Neurovascular Coupling: A Functional Transcranial Doppler Study
Kannaphob Ladthavorlaphatt (Thailand)
0:54:25
Sleep architectural changes during recurrent cycles of sleep restriction: comparing stable and variable short sleep schedules
Tiffany B. Koa (Singapore)
1:11:40
Dopaminergic Mechanisms Underpinning Excessive Daytime Sleepiness and Hypoglossal Nerve Stimulation Outcomes in OSA: Evidence from Transcriptomics and Animal Models
Yan Wang (China) -
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Benefits of Early Body Weight Reduction in Participants with Obesity and Moderate-to-severe Obstructive Sleep Apnea: A Post Hoc Analysis of SURMOUNT-OSA
Ying Ni Lin (China)
Recording not available: The Effect of Zolpidem on CPAP Acclimatization in Patients with OSA: A Crossover, Randomized, Double-blinded, Placebo-controlled Trial.
Piyakorn Pisalnoradej (Thailand)
0:14:23
The Effect of Telemedicine-Based CPAP Management on 24-Hour Ambulatory Blood Pressure in Patients with Obstructive Sleep Apnea: A Randomized, Controlled, Non-Inferiority Trial
Huiji Yi (China)
0:26:50
Real-World Evidence for Surgical and Nonsurgical Sleep Apnea Therapies: safety, Clinical Outcomes and Healthcare Utilization Patterns
Robson Capasso (United States)
0:48:45
Five-year, prospective, multicenter, real-world study to assess initial delivery, management and long-term effectiveness of a CAD/CAM, 3-D printed oral appliance in the treatment of obstructive sleep apnea: Interim Analysis Update
Robyn Woidtke (United States) -
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Efficacy of transcutaneous spinal direct current stimulation and pneumatic compression in restless legs syndrome and augmentation
Nikita Gorbachev (Russian Federation)
0:09:10
Tonic motor activation therapy in patients with painful versus painless restless legs: An interim 180-day results from the THRIVE study
Elias Karroum (United States)
0:20:50
Clinical Characteristics, Polysomnography, and Iron Metabolism in Restless Legs Syndrome Patients with Obstructive Sleep Apnea: A Comparative and Cluster Analysis Study
Yanyan Hou (China)
0:34:25
Clinical influence of restless legs syndrome in migraine patients: a 12-year single-center longitudinal study
Keisuke Suzuki (Japan)
0:46:30
Impact of Dopamine Agonists and Clonazepam on LMM and PLMS in RLS Patients
Maria Paola Mogavero (Italy)
Raffaele Ferri (Italy)
Recording not available: Neurological approaches to restless legs syndrome: a systematic review of non-pharmacological interventions
Joao Victor Pereira Gonzalez (Brazil) -
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Examining the impact of seasonal variations in photoperiod on sleep in young adults
Saranea Ganesan (United Kingdom)
0:10:00
Light Exposure Patterns and Human Health: Insights from Large-Scale Personal Light Tracking
Sean Cain (Australia)
0:24:20
Diurnal light exposure and circadian rest-activity rhythms with the risk of metabolic dysfunction-associated fatty liver disease
Hanshang Wu (China)
0:35:35
Light at Night Exacerbates Depression Risk via Circadian Disruption and Hippocampal Per1 Dysregulation: Translational Evidence from a Large-scale Prospective Cohort and Animal Study
Hongliang Feng (China)
0:50:40
Use of Apple Watch to Optimize Light Therapy and Reduce Circadian Misalignment for Night Shift Workers
Marleigh Treger (United States)
1:05:55
Blue light influences loss aversion
Alicia Lander (Australia) -
Contains 1 Component(s)
This Session has been made freely available as part of the Open Access Sessions bundle.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the course by navigating to the timestamp indicated below
0:00:00
Vibrance-1: A Randomized Phase 2 Study Evaluating Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680) in Patients with Narcolepsy Type 1
Giuseppe Plazzi (Italy)
0:13:50
Improvement in the Severity of Narcolepsy Symptoms and Fatigue in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)
Yves Dauvilliers (France)
0:24:50
Improvement in Patient-reported Cognitive Functioning in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)
Giuseppe Plazzi (Italy)
0:35:00
The First Light: Efficacy and Safety of a Multi-Dose Study of Oveporexton (TAK-861), an Oral Orexin Receptor 2 Agonist for the Treatment of Narcolepsy Type 1
Emmanuel Mignot (United States)
0:47:50
The Radiant Light: Efficacy and Safety of Oveporexton (TAK-861), an Oral Orexin Receptor 2 Agonist for the Treatment of Narcolepsy Type 1
Yves Dauvilliers (France)
1:01:25
Effect of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) on the Severity of Symptoms in Individuals With Narcolepsy Type 1: Results From Two Phase 3 Studies
Lucie Barateau (France)
1:14:45
Effect of the Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) on Quality of Life in Individuals with NT1 over 12 weeks
Sheila Sivam (Australia) -
Contains 1 Component(s)
This Session has been made freely available as part of the Open Access Sessions bundle.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Mindfulness-imbued insomnia therapy enhances antidepressant outcomes for pregnant women with insomnia and depression: A comparative effectiveness randomized controlled trial of CBTI and PUMAS
Heba Afaneh (United States)
0:14:25
Intensive Sleep Retraining and Total Sleep Deprivation for Treating Chronic Insomnia: A Randomised Controlled Trial
Charles Morin (Canada)
0:32:15
Effect of combined treatment with transcranial direct current stimulation and repetitive transcranial magnetic stimulation compared to monotherapy for the treatment of chronic insomnia: a randomised, double-blind, parallel-group, controlled trial
Qi Zhou (China)
0:46:55
Brain Network Study of Transcranial Plasma Therapy for Chronic Insomnia
Qinying Ma (China)
1:03:10
Novel Approach for Biologically-Guided Therapeutics in Insomnia
Carolina Gutierrez Herrera (Switzerland)
1:15:50
Effects of Music Presentation on Sleep Quality and Functional Connectivity in the Brain Estimated using EEG
Hiroto Irimajiri (Japan) -
Contains 1 Component(s)
This abstract session was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Autism, Sleep, and Medicinal Cannabis: Evaluating 18-Month Efficacy and Safety Outcomes
Mohsin Maqbool (United States)
Recording not available: Integrated metagenomic and metabolomic analysis reveal distinctive gut microbiota-derived metabolites in pediatric obstructive sleep apnea
Xiaoman Zhang (China)
0:14:55
Achieving recommended sleep duration and abdominal fat deposition: a sex-specific relationship in 10-year-old children
Shirong Cai (Singapore)
0:24:50
Can sleep spindle characteristics distinguish children with narcolepsy from those with idiopathic hypersomnia and subjective sleepiness?
Rosemary Horne (Australia)
0:37:20
The temporal associations between sleep and circadian preference, and mental health among Norwegian adolescents
Ingvild West Saxvig (Norway)
0:50:05
Beyond the recommendations: A bioecological analysis of pre-bedtime screen use, moderate-to-vigorous physical activity and food intake in family contexts
Chao Gu (New Zealand)
1:01:30
Question and Answer